A Major Product Planning Opportunity:
The Best Tools + Expertise =
The Best Product Planning!
MAX THE MOLECULE—the State-Of-The-Art Product Life Cycle Planning Program designed to maximize the profit on the hard work of your research division.
Our New Max the Molecule Version 2.0
is
Currently patent pending and more powerful than our earlier version
A unique, successful product
An integrated computer software program and spreadsheet application
Max the Molecule is a unique product that has already been applied successfully by numerous major pharmaceutical companies to
Determine whether or not to switch.
"Max" is completely objective and can result in
- No recommendation to switch
Switch at a certain point in time
Execute our specially created "Dual Status" strategy
|
Primary Strategic Objectives |
Major Therapies
Like Oncology |
Moderate Therapies
Like Lipid Lowering |
Mild Therapies
Like Allergy |
|
STRATEGIC ALTERNATIVES | | | | |
|
Traditional Rx Market Entry |
Maximize Rx market share and profit margin |
YES |
YES |
YES |
|
Rx generic (alone) after patent expiration |
Maximize Rx Profit Margin |
YES |
YES |
YES |
|
Rx generic (+ partner) after patent expiration |
Maximize Rx Total Share & Profit |
YES |
YES |
YES |
|
Complete Rx-to-OTC Switch after patent expiration |
Life Cycle extension and new market penetration |
NO |
PERHAPS |
YES |
|
Dual Status ** Rx-to-OTC Switch before patent expiration |
Maximizing profits from Two Businesses, incremental market |
NO |
PERHAPS |
YES |
** Dual status defined as simultaneous Rx and OTC existence, with the same brand name and both under patent protection for an extended time period.
Our MAX THE MOLECULE program is specifically designed to maximize product profit over the product's entire life cycle
TOP
Max the Molecule is an integrated computer software program and corresponding spreadsheet application.
Max the Molecule has been designed to be the most comprehensive and unbiased approach to product planning, particularly the inevitable change of status as the molecule goes through its life cycle. Max the Molecule thoroughly covers the critical importance of:
• Competitive positioning and product differentiation
• Rx heritage (molecule and brand)
• Profit, Net Present Value, Terminal Value
• Possible OTC indications
• Generic defense, Dual Status and potential OTC cannibalization
• Patent importance and switch timing
• Primary and secondary scenarios
• Plus ten factors we have identified as keys to successful switching
TOP
In today's increasingly competitive pharmaceutical market, you need all the help you can get, as long as it is the best. Francesco International and "Max the Molecule" are exactly that.
“MAX THE MOLECULE”— the State-Of-The-Art Product Life Cycle Planning Program designed to maximize the profit on the hard work of your research division
For further information on Max the Molecule stevef@franint.com.
Return to the
Top
Francesco International Tel 1-973-985-0589, Fax
1-973-761-6996,
stevef@franint.com
| 
